Current Neuropharmacology
Title:Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Volume: 16 Issue: 6
Author(s): Luciana Scotti*Marcus T. Scotti*
Affiliation:
- Federal University of Paraiba Campus I, 58051-900 Joao Pessoa-PB,Brazil
- Federal University of Paraiba Campus I, 58051-900 Joao Pessoa-PB,Brazil
Export Options
About this article
Cite this article as:
Scotti Luciana *, Scotti T. Marcus*, Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases, Current Neuropharmacology 2018; 16 (6) . https://dx.doi.org/10.2174/1570159X1606180608103840
DOI https://dx.doi.org/10.2174/1570159X1606180608103840 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
41
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Variability of Biological Activities of Limonoids Derived from Plant Sources
Mini-Reviews in Organic Chemistry Clinical Applications of Intravenous Immunoglobulins in Child Neurology
Current Pharmaceutical Biotechnology Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Disruption of Zinc Neuromodulation by Aß Oligomers : Therapeutic Implications
Current Pharmaceutical Design Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Targeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury
Current Pharmaceutical Design Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Recent Patents on CNS Drug Discovery (Discontinued) Stem Cell Behavior at Hypothermia: A Review Article
Current Stem Cell Research & Therapy Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Current Neuropharmacology Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention
Current Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Molecular Mechanism of a Specific NLRP3 Inhibitor to Alleviate Seizure Severity Induced by Pentylenetetrazole
Current Molecular Pharmacology Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments
Current Pharmaceutical Design Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease
Current Aging Science Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
Current Radiopharmaceuticals Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry